Literature DB >> 23878141

Treatment of acquired von Willebrand syndrome in childhood.

Michael U Callaghan1, Trisha E Wong, Augusto B Federici.   

Abstract

A 3-1/2-year-old male with no personal or family history of bleeding disorders presented with abdominal distension, epistaxis, and anemia (hemoglobin 8.2 g/dL). A magnetic resonance imaging scan of the abdomen demonstrated a mass arising from the left kidney. Preoperative laboratory studies revealed a prolonged activated partial thromboplastin time of 49.2 seconds, a normal prothrombin time of 12.4 seconds, and a platelet count of 230, 000/μL. Further testing revealed factor VIII (FVIII) activity of 16%, factor IX (FIX) activity of 74%, von Willebrand factor (VWF) activity of 12%, VWF antigen activity of 31%, and decreased high-molecular-weight VWF multimers consistent with acquired von Willebrand syndrome (AVWS). What is the best treatment for this child?

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23878141     DOI: 10.1182/blood-2012-10-435719

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.

Authors:  Adrienne Lee; Gary Sinclair; Karen Valentine; Paula James; Man-Chiu Poon
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

2.  Perioperative intravenous immunoglobulin treatment in a patient with severe acquired von Willebrand syndrome: case report and review of the literature.

Authors:  Eva Jennes; Dorothee Guggenberger; Rainer Zotz; Lora Thompson; Tim H Brümmendorf; Steffen Koschmieder; Edgar Jost
Journal:  Clin Case Rep       Date:  2017-03-30

Review 3.  New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand Syndrome.

Authors:  Frank W G Leebeek
Journal:  Hemasphere       Date:  2021-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.